What is LifeVac?

The vision of LifeVac came from a story that Arthur Lih, founder and CEO of LifeVac, heard a woman in a hospital weeping following the death of her young son, after choking on a simple grape.

The reason for his death was that the grape had become lodged in his windpipe and could not be dislodged. Once he heard the story he set out to invent an apparatus that could clear the airway of a child in the event of choking and save lives.

Arthur, Dr. Brody, and a few close friends set out to bring LifeVac to the public by establishing a research and development facility located in Springfield Gardens, NY where they are producing the anti-choking device in order to bring the safest, simplest method to save a choking victim. Our goal is to save as many lives as possible throughout the world.

LifeVac South East Europe was established in 2017 to distribute this life saying technology in South East Europe.

Device Certifications & Studies

DoC Certification

LifeVac carries from 2016 a EC Declaration of Conformity under directive EC 93/42/EEC of the European Union

MHRA Certification

LifeVac is registered in the U.K. by the Medicines and Healthcare Products Regulatory Agency (MHRA) and carries a CE conformity certificate.

FDA Certification

LifeVac has been listed in the ARTG Number 285082

Health Canada

LifeVac is licenced in Canada as a medical device by Health Canada

ARTG Certificate

LifeVac has been listed in the ARTG Number 285082.

Clinical Evaluation Report

LifeVac – Class I Medical Device

Simulation Study

A novel apparatus for the resuscitation of a choking victim.

American Journal of Emergency Medicine

Assessment of the LifeVac,an Anti-Choking Device

Global Research Project

LifeVac Europe are pleased to be taking a huge step forward in regards to reaching our ultimate goal, to have non-invasive airway clearance devices implemented into BLS choking protocol.

LifeVac Europe are pleased to be taking a huge step forward in
regards to reaching our ultimate goal, to have non-invasive
airway clearance devices implemented into BLS choking protocol.

LifeVac to date (16 June 2022) has saved over 389 lives in a choking emergency when BLS choking protocol has failed or cannot be performed.

These lives saved in conjunction with the multiple peer reviewed medical publications on lives saved, safety, independent testing, effectiveness and usability, show the need for such an implementation.

This would save hundreds of thousands of lives every year around the world in a choking emergency.

We are interested in learning about your experience with the LifeVac Device!

Researchers are conducting a study looking at the benefits and harms (pros and cons) of using airway clearance devices (ACDs) on someone who is choking.

Traditional choking interventions (like abdominal thrusts, back blows, and chest compression’s) have been recommended for decades, but recently ACDs have become a potential alternative to the traditional techniques. This study aims to improve the data about these devices.

Click the link below to learn more about the study, and to share your LifeVac experience. We appreciate your time and help.

Click here to take this survey.

Shopping Cart
Scroll to Top